Cargando...
Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.
Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...
Guardado en:
| Publicado en: | J Clin Pathol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1982
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|